Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Aligos Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −4 vs. Q2 2025
- Shares held
- 2.65M
- −54.6K (−2.0%) vs. Q2 2025
- Total value
- $26.0M
- +$6.48M (+33.2%) vs. Q2 2025
- New holders
- 5
- 11 more added
- Sold out
- 9
- 6 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 3 | $29 | 0.00% | −1,813−99.8% | Reduced |
| ZRC Wealth Management, LLC | 4 | $40 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 15 | $147 | 0.00% | +15 | New |
| SBI Securities Co., Ltd. | 26 | $255 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 457 | $4.48K | 0.00% | −646−58.6% | Reduced |
| JPMorgan Chase & Co | 708 | $6.94K | 0.00% | +682+2,623.1% | Added |
| Global Retirement Partners, LLC | 800 | $7.84K | 0.00% | +800 | New |
| Rockefeller Capital Management L.P. | 1,000 | $9.80K | 0.00% | +1,000 | New |
| Bank of America Corp | 1,914 | $18.8K | 0.00% | −698−26.7% | Reduced |
| Royal Bank of Canada | 2,125 | $21.0K | 0.00% | 00.0% | Unchanged |
| Golden State Wealth Management, LLC | 2,674 | $26.2K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,170 | $31.1K | 0.00% | −10,600−77.0% | Reduced |
| Quest Partners LLC | 6,772 | $66.4K | 0.00% | +829+13.9% | Added |
| NorthCrest Asset Manangement, LLC | 10,000 | $98.4K | 0.00% | +10,000 | New |
| Susquehanna International Group, LLP | 10,107 | $99.0K | 0.00% | +10,107 | New |
| Citadel Advisors LLC | 10,310 | $101.0K | 0.00% | −4,888−32.2% | Reduced |
| Morgan Stanley | 11,284 | $110.6K | 0.00% | +7,279+181.7% | Added |
| BlackRock, Inc. | 13,040 | $127.8K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 16,182 | $158.6K | 0.00% | +13,439+489.9% | Added |
| Squarepoint Ops LLC | 30,493 | $298.8K | 0.00% | +11,904+64.0% | Added |
| Two Sigma Investments, LP | 38,995 | $382.2K | 0.00% | +26,922+223.0% | Added |
| Geode Capital Management, LLC | 47,080 | $461.6K | 0.00% | +13,032+38.3% | Added |
| Renaissance Technologies LLC | 55,019 | $539.2K | 0.00% | +2,475+4.7% | Added |
| LPL Financial LLC | 55,120 | $540.2K | 0.00% | +25,020+83.1% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 76,247 | $747.2K | 0.02% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 83,055 | $813.9K | 0.01% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 140,000 | $1.37M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 171,689 | $1.68M | 0.00% | +31,913+22.8% | Added |
| Readystate Asset Management LP | 203,113 | $1.99M | 0.10% | +66,331+48.5% | Added |
| Sio Capital Management, LLC | 335,937 | $3.29M | 0.83% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 412,000 | $4.04M | 0.01% | 00.0% | Unchanged |
| Deep Track Capital, LP | 444,110 | $4.35M | 0.12% | 00.0% | Unchanged |
| Woodline Partners LP | 468,199 | $4.59M | 0.02% | −50,101−9.7% | Reduced |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −141,131−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −25,398−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −13,849−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −12,315−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,231−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −3,913−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −220−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |